バイオプロセスバリデーションサービスの世界市場 - 2024年までの予測：フィルターエレメント、バイオリアクター

世界のバイオプロセスバリデーションサービス市場は、2019年の1億8000万米ドルから、2024年までに3億6000万米ドルまで拡大すると見られています。市場は、2019年～2024年のCAGR (複合年間成長率) で、14.6％の成長が予測されています。

当レポートでは、世界のバイオプロセスバリデーションサービス市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

• バイオプロセスバリデーションサービス：市場概要
• アジア太平洋地域 - バイオプロセスバリデーションサービス市場：エンドユーザー別
• バイオプロセスバリデーションサービス市場の地域別スナップショット
• 地域構成：バイオプロセスバリデーションサービス市場
• バイオプロセスバリデーションサービス市場：途上国 vs. 先進国

第5章 市場概要

• イントロダクション
• 市場力学：影響分析
  • 促進要因
  • 抑制要因
  • 機会
  • 課題

第6章 産業考察

• 産業動向
• バイオプロセスバリデーションの規制ガイドライン

第7章 バイオプロセスバリデーションサービスの世界市場：テストの種類別

• イントロダクション
• 抽出性/浸出性
• 微生物
• 生理化学
• 完全性
• 互換性
• その他

第8章 バイオプロセスバリデーションサービスの世界市場：プロセスのコンポーネント別

• イントロダクション
• フィルターエレメント
• メディアコンテナ・バッグ
• プロセスバッグの冷凍・解凍
• 混合システム
• バイオリアクター
• 移行システム
• その他

第9章 バイオプロセスバリデーションサービスの世界市場：エンドユーザー別

• イントロダクション
• 製薬企業
• 受託開発・製造機関
• バイオテクノロジー企業
• その他

第10章 バイオプロセスバリデーションサービスの世界市場：地域別

• イントロダクション
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第11章 競合情勢

• 概要
• 市場シェア分析
• 競合リーダーシップマッピング
• ベンダー選定基準
• ベンダー分析
• 競合状況・動向
• サービスのポートフォリオ分析

第12章 企業プロファイル

• MERCK KGAA
• PALL CORPORATION (DANAHER CORPORATIONの一部)
• SARTORIUS STEDIM BIOTECH S.A.
• SGS S.A.
• EUROFINS SCIENTIFIC
• COBETTER FILTRATION EQUIPMENT CO., LTD.
• TOXIKON CORPORATION
• DOC S.R.L.
• MEISSNER FILTRATION PRODUCTS, INC.
• THERMO FISHER SCIENTIFIC, INC.
• その他の企業プロファイル

第13章 付録

LIST OF TABLES

• TABLE 1: STANDARD CURRENCY CONVERSION RATES
• TABLE 2: BIOPROCESS VALIDATION SERVICES MARKET SNAPSHOT, 2019 VS. 2024
• TABLE 3: TYPICAL EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS
• TABLE 4: COMPARISON OF BIOPROCESSING SYSTEM DISPOSAL OPTIONS
• TABLE 5: MAJOR EXPANSIONS IN THE BIOPROCESS VALIDATION SERVICES MARKET (2016-2019)
• TABLE 6: REGULATIONS & STANDARDS GOVERNING BIOPROCESS VALIDATION
• TABLE 7: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 8: KEY PROVIDERS OF EXTRACTABLES/LEACHABLES TESTING SERVICES
• TABLE 9: EXTRACTABLES/LEACHABLES TESTING SERVICES MARKET , BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 10: KEY PROVIDERS OF MICROBIOLOGICAL TESTING SERVICES
• TABLE 11: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 12: MICROBIOLOGICAL TESTING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 13: LARGE-SCALE EUKARYOTIC CELL CULTURE TESTING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 14: VIRUS PRODUCTION & PURIFICATION TESTING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 15: ELECTRON MICROSCOPY TESTING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 16: KEY PROVIDERS OF PHYSIOCHEMICAL TESTING SERVICES
• TABLE 17: PHYSIOCHEMICAL TESTING SERVICES MARKET , BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 18: KEY PROVIDERS OF INTEGRITY TESTING SERVICES
• TABLE 19: INTEGRITY TESTING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 20: KEY PROVIDERS OF COMPATIBILITY TESTING SERVICES
• TABLE 21: COMPATIBILITY TESTING SERVICES MARKET , BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 22: OTHER TESTING SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 23: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 24: BIOPROCESS VALIDATION SERVICES MARKET FOR FILTER ELEMENTS, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 25: BIOPROCESS VALIDATION SERVICES MARKET FOR MEDIA CONTAINERS AND BAGS, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 26: BIOPROCESS VALIDATION SERVICES MARKET FOR FREEZING AND THAWING PROCESS BAGS, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 27: BIOPROCESS VALIDATION SERVICES MARKET FOR MIXING SYSTEMS, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 28: BIOPROCESS VALIDATION SERVICES MARKET FOR BIOREACTORS, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 29: BIOPROCESS VALIDATION SERVICES MARKET FOR TRANSFER SYSTEMS, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 30: BIOPROCESS VALIDATION SERVICES MARKET FOR OTHER PROCESS COMPONENTS, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 31: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 32: BIOPROCESS VALIDATION SERVICES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 33: BIOPROCESS VALIDATION SERVICES MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 34: BIOPROCESS VALIDATION SERVICES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 35: BIOPROCESS VALIDATION SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 36: BIOPROCESS VALIDATION SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
• TABLE 37: NORTH AMERICA: BIOPROCESS VALIDATION SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 38: NORTH AMERICA: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 39: NORTH AMERICA: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 40: NORTH AMERICA: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 41: NORTH AMERICA: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 42: US: KEY MACROINDICATORS
• TABLE 43: US: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 44: US: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 45: US: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 46: US: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 47: CANADA: KEY MACROINDICATORS
• TABLE 48: CANADA: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 49: CANADA: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 50: CANADA: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 51: CANADA: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 52: EUROPE: BIOPROCESS VALIDATION SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 53: EUROPE: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 54: EUROPE: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 55: EUROPE: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 56: EUROPE: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 57: GERMANY: KEY MACROINDICATORS
• TABLE 58: GERMANY: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 59: GERMANY: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 60: GERMANY: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 61: GERMANY: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 62: FRANCE: KEY MACROINDICATORS
• TABLE 63: FRANCE: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 64: FRANCE: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 65: FRANCE: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 66: FRANCE: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 67: UK: KEY MACROINDICATORS
• TABLE 68: UK: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 69: UK: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 70: UK: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 71: UK: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 72: ITALY: KEY MACROINDICATORS
• TABLE 73: ITALY: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 74: ITALY: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 75: ITALY: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 76: ITALY: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 77: SPAIN: KEY MACROINDICATORS
• TABLE 78: SPAIN: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 79: SPAIN: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 80: SPAIN: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 81: SPAIN: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 82: ROE: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 83: ROE: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 84: ROE: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 85: ROE: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 86: APAC: BIOPROCESS VALIDATION SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 87: APAC: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 88: APAC: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 89: APAC: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 90: APAC: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 91: CHINA: KEY MACROINDICATORS
• TABLE 92: CHINA: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 93: CHINA: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 94: CHINA: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 95: CHINA: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 96: JAPAN: KEY MACROINDICATORS
• TABLE 97: JAPAN: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 98: JAPAN: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 99: JAPAN: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 100: JAPAN: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 101: INDIA: KEY MACROINDICATORS
• TABLE 102: INDIA: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 103: INDIA: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 104: INDIA: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 105: INDIA: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 106: ROAPAC: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 107: ROAPAC: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 108: ROAPAC: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 109: ROAPAC: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 110: LATIN AMERICA: BIOPROCESS VALIDATION SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
• TABLE 111: LATIN AMERICA: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 112: LATIN AMERICA: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 113: LATIN AMERICA: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 114: LATIN AMERICA: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 115: BRAZIL: KEY MACROINDICATORS
• TABLE 116: BRAZIL: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 117: BRAZIL: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 118: BRAZIL BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 119: BRAZIL: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 120: MEXICO: KEY MACROINDICATORS
• TABLE 121: MEXICO: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 122: MEXICO: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 123: MEXICO: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 124: MEXICO: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 125: ROLA: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 126: ROLA: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 127: ROLA: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 128: ROLA: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 129: MEA: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2017-2024 (USD MILLION)
• TABLE 130: MEA: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
• TABLE 131: MEA: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2017-2024 (USD MILLION)
• TABLE 132: MEA: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2017-2024 (USD MILLION)
• TABLE 133: GROWTH STRATEGY MATRIX (2015-2018)
• TABLE 134: EXPANSIONS, 2016-2019
• TABLE 135: ACQUISITIONS, 2016-2019
• TABLE 136: COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2016-2019
• TABLE 137: SERVICE LAUNCHES, 2016-2019

LIST OF FIGURES

• FIGURE 1: RESEARCH DESIGN
• FIGURE 2: PRIMARY SOURCES
• FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
• FIGURE 5: BOTTOM-UP APPROACH
• FIGURE 6: TOP-DOWN APPROACH
• FIGURE 7: DATA TRIANGULATION METHODOLOGY
• FIGURE 8: BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE, 2019 VS. 2024 (USD MILLION)
• FIGURE 9: MICROBIOLOGICAL TESTING SERVICES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
• FIGURE 10: BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT, 2019 VS. 2024 (USD MILLION)
• FIGURE 11: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
• FIGURE 12: GEOGRAPHICAL SNAPSHOT OF THE BIOPROCESS VALIDATION SERVICES MARKET
• FIGURE 13: INCREASING NUMBER OF STRINGENT SAFETY AND QUALITY REGULATIONS IN THE BIOPHARMACEUTICAL INDUSTRY IS DRIVING MARKET GROWTH
• FIGURE 14: PHARMACEUTICAL COMPANIES COMMANDED THE LARGEST SHARE OF THE APAC BIOPROCESS VALIDATION SERVICES MARKET IN 2018
• FIGURE 15: CHINA IS ESTIMATED TO GROW AT A HIGHEST CAGR DURING THE FORECAST PERIOD
• FIGURE 16: ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
• FIGURE 17: DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
• FIGURE 18: US: BIOLOGICS GOING OFF-PATENT IN THE COMING YEARS
• FIGURE 19: EXTRACTABLES/LEACHABLES TESTING SERVICES TO WITNESS HIGH GROWTH IN THE BIOPROCESS VALIDATION SERVICES MARKET DURING THE FORECAST PERIOD
• FIGURE 20: LARGE-SCALE EUKARYOTIC CELL CULTURE SERVICES TO WITNESS HIGH GROWTH IN THE BIOPROCESS VALIDATION SERVICES MARKET DURING THE FORECAST PERIOD
• FIGURE 21: FILTER ELEMENTS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE BIOPROCESS VALIDATION SERVICES MARKET DURING THE FORECAST PERIOD
• FIGURE 22: PHARMACEUTICAL COMPANIES TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
• FIGURE 23: GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA PACIFIC ARE EMERGING HOTSPOTS
• FIGURE 24: NORTH AMERICA: BIOPROCESS VALIDATION SERVICES MARKET SNAPSHOT
• FIGURE 25: EUROPE: BIOPROCESS VALIDATION SERVICES MARKET SNAPSHOT
• FIGURE 26: APAC: BIOPROCESS VALIDATION SERVICES MARKET SNAPSHOT
• FIGURE 27: KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2016 AND FEBRUARY 2019
• FIGURE 28: BIOPROCESS VALIDATION SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
• FIGURE 29: COMPETITIVE LEADERSHIP MAPPING, BIOPROCESS VALIDATION SERVICES MARKET (2019)
• FIGURE 30: EXPANSIONS WAS THE KEY GROWTH STRATEGY ADOPTED BY MAJOR PLAYERS BETWEEN 2016 & 2019
• FIGURE 31: MERCK KGAA: COMPANY SNAPSHOT
• FIGURE 32: SARTORIUS STEDIM BIOTECH S.A.: COMPANY SNAPSHOT
• FIGURE 33: SGS S.A.: COMPANY SNAPSHOT
• FIGURE 34: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
• FIGURE 35: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

"The bioprocess validation market is estimated to grow at a CAGR of 14.6%"

The global bioprocess validation market is exceeded USD 180 million in 2019 and is projected to be valued over USD 360 million by 2024, at a CAGR of 14.6% during the forecast period. The growth of the bioprocess validation services market is driven primarily by the stringent safety and quality regulations governing product certification and testing across the biopharmaceutical and pharmaceutical industries. This has also stimulated the demand for the outsourcing of bioprocess validation services. The rising R&D spending in the life science industry has contributed to this demand significantly, while the growing demand for bioprocess validation in emerging countries and patent expiries have ensured steady market growth. However, the issues related to extractable and leachable testing affect market growth to a certain extent during the forecast period.

"Extractables/leachables testing services segment to witness the highest growth during the forecast period"

The combination systems segment is estimated to grow at the highest CAGR during the forecast period. This can primarily be attributed to increasing outsourcing of testing services by biopharmaceutical manufacturers; the presence of regulatory mandates and guidelines regarding the testing of extractables & leachables; and growing product safety, identity, purity, and quality; and the increasing risk of product adulteration related requirement.

"Filter elements segment to grow at the highest CAGR in the bioprocess validation market, by process component"

The major factors driving the demand for filter elements in bioprocess validation are stringent regulations and industry standards for biopharmaceutical products; increasing usage of a variety of filters in bioprocessing; and the high demand for the evaluation of specific filter elements and their impact on the final drug product owing to the factors such as safety and efficacy of biopharmaceutical products.

"APAC market to witness the highest growth during the forecast period"

The Asia Pacific is estimated to be the fastest-growing regional market for bioprocess validation during the forecast period. The growing biopharmaceutical manufacturing capabilities in Asian countries, increasing demand for outsourcing bioprocess validation, growing life science research specific to biologics, increasing investments by pharmaceutical & biotechnology companies, rising awareness about the advantages of biopharmaceutical drugs, increasing number of CROs & CDMOs, and the favorable government initiatives to promote the growth of the pharmaceutical & biotechnology industries in several APAC countries are some of the major factors driving the growth of this market.

A breakdown of the primary participants in this report is provided below:

• By Company Type: Tier 1-46%, Tier 2-33%, and Tier 3-21%

• By Designation: C-level-43%, Director Level-35%, and Others-22%

• By Region: North America-34%, Europe-26%, Asia Pacific-19%, Latin America-11%, and the Middle East & Africa-10%

The prominent players operating in the global bioprocess validation market are: Merck KGaA (Germany), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Sartorius Stedim Biotech (France), Pall Corporation (US), Cobetter Filtration Equipments Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), and Thermo Fisher Scientific (US).

Research Coverage:

This report analyzes the market for various bioprocess validation and their adoption patterns. It aims at estimating the size and future growth potential of the global bioprocess validation market as well as its segments (by test type, process component, end-user, and region). The report also includes an in-depth competitive analysis of key market players along with their company profiles, service offerings, and recent developments.

Reasons to Buy the Report:

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or any combination of the below mentioned five strategies for strengthening their market presence.

• Market Penetration: Comprehensive information on the service portfolios offered by the top players in the global bioprocess validation market

• Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and service launches in the global bioprocess validation market

• Market Development: Comprehensive information on the lucrative emerging regions

• Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the global bioprocess validation market

• Competitive Assessment: In-depth assessment of services offered, market shares, growth strategies, and revenue analysis of leading players in the global bioprocess validation market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED FOR THE STUDY
• 1.4 CURRENCY
• 1.5 LIMITATIONS
• 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 BIOPROCESS VALIDATION SERVICES: MARKET OVERVIEW
• 4.2 ASIA PACIFIC: BIOPROCESS VALIDATION SERVICES MARKET, BY END USER (2018)
• 4.3 GEOGRAPHICAL SNAPSHOT OF THE BIOPROCESS VALIDATION SERVICES MARKET
• 4.4 REGIONAL MIX: BIOPROCESS VALIDATION SERVICES MARKET
• 4.5 BIOPROCESS VALIDATION SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS: IMPACT ANALYSIS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Stringent safety and quality regulations
    • 5.2.1.2 Increasing demand for biopharmaceuticals
    • 5.2.1.3 Increasing demand for outsourcing bioprocess validation
    • 5.2.1.4 Rising life science R&D expenditure
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Issues related to extractables & leachables
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth opportunities in Asia Pacific and Latin American countries
    • 5.2.3.2 Patent expiry
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Waste disposal
    • 5.2.4.2 Development of new validation methods for next generation bioproducts

6 INDUSTRY INSIGHTS

• 6.1 INDUSTRY TRENDS
  • 6.1.1 AUTOMATION IN BIOPROCESS VALIDATION SERVICES
  • 6.1.2 GEOGRAPHIC EXPANSIONS BY MARKET PLAYERS
• 6.2 REGULATORY GUIDELINES FOR BIOPROCESS VALIDATION

7 BIOPROCESS VALIDATION SERVICES MARKET, BY TEST TYPE

• 7.1 INTRODUCTION
• 7.2 EXTRACTABLES/LEACHABLES TESTING SERVICES
  • 7.2.1 SPECIFICATIONS AND GUIDELINES FOR EXTRACTABLES/ LEACHABLES TESTING HAVE ENSURED THE CONTINUED DEMAND FOR THESE SERVICES
• 7.3 MICROBIOLOGICAL TESTING SERVICES
  • 7.3.1 LARGE-SCALE EUKARYOTIC CELL CULTURE TESTING SERVICES
    • 7.3.1.1 North America shows the highest demand for large-scale eukaryotic cell culture testing services
  • 7.3.2 VIRUS PRODUCTION & PURIFICATION TESTING SERVICES
    • 7.3.2.1 Increased concerns of viral contaminant presence in raw materials are driving the adoption of testing services
  • 7.3.3 ELECTRON MICROSCOPY TESTING SERVICES
    • 7.3.3.1 Electron microscopy provides high-resolution images of specimens present in bioprocesses
• 7.4 PHYSIOCHEMICAL TESTING SERVICES
  • 7.4.1 NEED FOR DETECTION AND CHARACTERIZATION OF IMPURITIES IN THE FINAL PRODUCT IS DRIVING MARKET GROWTH
• 7.5 INTEGRITY TESTING SERVICES
  • 7.5.1 INTEGRITY TESTING IS VITAL TO DETECT WEAR AND TEAR AND PRESSURE-CAUSED DAMAGE
• 7.6 COMPATIBILITY TESTING SERVICES
  • 7.6.1 DEMAND FOR EVALUATING PROCESS COMPONENT-FORMULATION INTERACTION HAS NECESSITATED COMPATIBILITY TESTING
• 7.7 OTHER TESTING SERVICES

8 BIOPROCESS VALIDATION SERVICES MARKET, BY PROCESS COMPONENT

• 8.1 INTRODUCTION
• 8.2 FILTER ELEMENTS
  • 8.2.1 STRINGENT REGULATIONS FOR BIOPHARMACEUTICAL PRODUCTS ARE DRIVING THE GROWTH OF THIS SEGMENT
• 8.3 MEDIA CONTAINERS AND BAGS
  • 8.3.1 VALIDATION AND QUALIFICATION OF MEDIA CONTAINERS AND BAGS IS NECESSARY TO MAINTAIN THE SAFETY OF THE FINAL BIOPHARMACEUTICAL PRODUCT
• 8.4 FREEZING AND THAWING PROCESS BAGS
  • 8.4.1 THE HIGH RISK OF SEAL LEAKS IN THE PRE-FREEZING AND THAWING STAGE IS DRIVING MARKET GROWTH
• 8.5 MIXING SYSTEMS
  • 8.5.1 GROWING NEED TO MEET FDA AND OTHER REGULATORY GUIDELINES DURING THE MIXING OF INGREDIENTS TO MAINTAIN PRODUCT QUALITY IS A KEY DRIVER
• 8.6 BIOREACTORS
  • 8.6.1 BIOPHARMACEUTICAL COMPANIES ARE INCREASINGLY ADOPTING BIOPROCESS VALIDATION SERVICES FOR BIOREACTORS TO LOWER THE RISK OF CROSS-CONTAMINATION
• 8.7 TRANSFER SYSTEMS
  • 8.7.1 THE NECESSITY TO MAINTAIN STERILE CONDITIONS DURING TRANSFER IS DRIVING THE MARKET
• 8.8 OTHER PROCESS COMPONENT

9 BIOPROCESS VALIDATION SERVICES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 PHARMACEUTICAL COMPANIES
  • 9.2.1 INCREASING PRODUCTION VOLUME HAS ENABLED PHARMA COMPANIES TO DOMINATE THE END-USER MARKET
• 9.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS
  • 9.3.1 EMERGING COUNTRIES HAVE BECOME KEY HUBS FOR THE OUTSOURCING OF PRODUCTION AND VALIDATION PROCESSES
• 9.4 BIOTECHNOLOGY COMPANIES
  • 9.4.1 NEED FOR REGULATORY COMPLIANCE HAS DRIVEN THE DEMAND FOR BIOPROCESS VALIDATION IN BIOTECH COMPANIES
• 9.5 OTHER END USERS

10 BIOPROCESS VALIDATION SERVICES MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 US
    • 10.2.1.1 US dominated the North American bioprocess validation services market in 2018
  • 10.2.2 CANADA
    • 10.2.2.1 Growing investments in the Canadian biopharmaceuticals sector to support market growth during the forecast period
• 10.3 EUROPE
  • 10.3.1 GERMANY
    • 10.3.1.1 Germany accounted for the largest share of the European bioprocess validation services market in 2018
  • 10.3.2 FRANCE
    • 10.3.2.1 High demand for biologics and implementation of favorable government initiatives to drive the demand for bioprocess validation services in France
  • 10.3.3 UK
    • 10.3.3.1 Growing demand for outsourcing compliance-related testing services in biopharmaceutical production to support market growth in the UK
  • 10.3.4 ITALY
    • 10.3.4.1 Growing biopharmaceutical manufacturing to drive the adoption of bioprocess validation services in Italy
  • 10.3.5 SPAIN
    • 10.3.5.1 High consumption of biologics to support the growth of the bioprocess validation services market in Spain
  • 10.3.6 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 CHINA
    • 10.4.1.1 China is one of the most-preferred destinations for leading biopharmaceutical companies for biologics production
  • 10.4.2 JAPAN
    • 10.4.2.1 Japan is one of the largest and most established markets for pharmaceutical products in the Asia Pacific
  • 10.4.3 INDIA
    • 10.4.3.1 Rising volume of biopharmaceutical production to drive market growth in India
  • 10.4.4 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 BRAZIL
    • 10.5.1.1 Growing investments in biopharmaceutical research to drive market growth in Brazil
  • 10.5.2 MEXICO
    • 10.5.2.1 Strong presence of global pharmaceutical companies in the country to support market growth
  • 10.5.3 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 MARKET SHARE ANALYSIS
• 11.3 COMPETITIVE LEADERSHIP MAPPING, 2018
• 11.4 VENDOR INCLUSION CRITERIA
• 11.5 VENDOR DIVE
  • 11.5.1 VISIONARY LEADERS
  • 11.5.2 INNOVATORS
  • 11.5.3 EMERGING COMPANIES
  • 11.5.4 DYNAMIC DIFFERENTIATORS
• 11.6 COMPETITIVE SITUATIONS AND TRENDS
  • 11.6.1 ACQUISITIONS
  • 11.6.2 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
  • 11.6.3 SERVICE LAUNCHES
• 11.7 SERVICE PORTFOLIO ANALYSIS
  • 11.7.1 SERVICE PORTFOLIO ANALYSIS

12 COMPANY PROFILES

(Business overview, Services offered, Recent developments, MNM view, SWOT analysis)*

• 12.1 MERCK KGAA
• 12.2 PALL CORPORATION (A PART OF DANAHER CORPORATION)
• 12.3 SARTORIUS STEDIM BIOTECH S.A.
• 12.4 SGS S.A.
• 12.5 EUROFINS SCIENTIFIC
• 12.6 COBETTER FILTRATION EQUIPMENT CO., LTD.
• 12.7 TOXIKON CORPORATION
• 12.8 DOC S.R.L.
• 12.9 MEISSNER FILTRATION PRODUCTS, INC.
• 12.10 THERMO FISHER SCIENTIFIC, INC.
• 12.11 ADDITIONAL COMPANY PROFILES
  • 12.11.1 PORVAIR PLC
  • 12.11.2 BIOZEEN
  • 12.11.3 TIANSHAN (TS FILTER) PRECISION FILTER MATERIAL CO., LTD.
  • 12.11.4 HANGZHOU ANOW MICROFILTRATION CO., LTD.
  • 12.11.5 ALMAC GROUP

Business overview, Services offered, Recent developments, MNM view, SWOT analysis might not be captured in case of unlisted companies.

13 APPENDIX

• 13.1 INSIGHTS OF INDUSTRY EXPERTS
• 13.2 DISCUSSION GUIDE
• 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.4 AVAILABLE CUSTOMIZATIONS
• 13.5 RELATED REPORTS
• 13.6 AUTHOR DETAILS